Vor BioPharma Shares Surge After $55.6 Million Placement

Vor BioPharma's shares saw a significant increase, rising by up to 33% on Friday following the announcement of a private placement of $55.6 million in shares.

Private Placement Details

Under the agreement, Vor Bio will issue approximately 55.9 million shares of common stock, along with warrants to purchase about 69.8 million additional shares.

Future Plans

The company also revealed plans to release updated clinical data from its VBP301 and VBP101 trials next year. The funds raised from the placement are anticipated to extend Vor's cash runway until the data releases in 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.